Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis
- PMID: 7888151
- DOI: 10.1007/BF01277964
Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis
Abstract
Neurotrophic factors are important for neuronal survival and maintenance in the adult nervous system. The regional distribution of insulin-like growth factor-1 (IGF-1) receptors in human spinal cords from controls and amyotrophic lateral sclerosis (ALS) patients was studied by immunohistochemistry and quantitative autoradiography. When comparing 125I-IGF-1 binding in the different spinal levels of normal spinal cord the same distribution pattern was found in which the binding was highest in the central canal > dorsal horn > ventral horn > white matter. In the ALS cases although a general upregulation of IGF-1 receptors was observed throughout the spinal cord, significant increases were observed in the cervical and sacral segments compared to controls. IGF-1 receptor immunoreactivity showed a similar pattern to that for 125I-IGF-1 binding, with immunoreactivity being found in the gray matter of the spinal cord and enhanced immunoreactivity occuring in ALS patients compared to controls. In agreement with the distribution of IGF-1 receptors, IGF-1 immunoreactivity was found within the gray matter of the spinal cord. The cartography of IGF-1 receptors in the normal spinal cord as well as the change of these receptors in diseased spinal cord may be of importance in future treatment strategies of ALS.
Similar articles
-
Growth factor receptors in amyotrophic lateral sclerosis.Mol Neurobiol. 1994 Aug-Dec;9(1-3):225-31. doi: 10.1007/BF02816121. Mol Neurobiol. 1994. PMID: 7888098
-
Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):128-33. doi: 10.1016/0169-328x(96)00081-2. Brain Res Mol Brain Res. 1996. PMID: 8883943
-
Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis.Lancet. 2003 Mar 22;361(9362):1007-11. doi: 10.1016/S0140-6736(03)12828-0. Lancet. 2003. PMID: 12660059
-
Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.Exp Neurol. 1993 Nov;124(1):73-88. doi: 10.1006/exnr.1993.1177. Exp Neurol. 1993. PMID: 8282084 Review.
-
A review of the functional role and of the expression profile of retinoid signaling and of nuclear receptors in human spinal cord.Brain Res Bull. 2007 Mar 15;71(5):437-46. doi: 10.1016/j.brainresbull.2006.10.032. Epub 2006 Dec 1. Brain Res Bull. 2007. PMID: 17259011 Review.
Cited by
-
Treatment of amyotrophic lateral sclerosis.Drugs Aging. 1999 Mar;14(3):173-96. doi: 10.2165/00002512-199914030-00003. Drugs Aging. 1999. PMID: 10220104 Review.
-
Motor neuron trophic factors: therapeutic use in ALS?Brain Res Rev. 2011 Jun 24;67(1-2):1-39. doi: 10.1016/j.brainresrev.2010.10.003. Epub 2010 Oct 21. Brain Res Rev. 2011. PMID: 20971133 Free PMC article. Review.
-
Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients.J Neural Transm (Vienna). 2011 Apr;118(4):531-8. doi: 10.1007/s00702-010-0520-6. Epub 2010 Nov 11. J Neural Transm (Vienna). 2011. PMID: 21069391
-
Impact of treadmill running and sex on hippocampal neurogenesis in the mouse model of amyotrophic lateral sclerosis.PLoS One. 2012;7(4):e36048. doi: 10.1371/journal.pone.0036048. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558322 Free PMC article.
-
The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.Neurosci Biobehav Rev. 2016 Apr;63:207-22. doi: 10.1016/j.neubiorev.2016.01.001. Epub 2016 Jan 15. Neurosci Biobehav Rev. 2016. PMID: 26780584 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous